ORTHOPEDIATRICS CORP (KIDS)
US68752L1008 - Common Stock
We assign a fundamental rating of 3 out of 10 to KIDS. KIDS was compared to 195 industry peers in the Health Care Equipment & Supplies industry. KIDS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. KIDS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
KIDS had negative earnings in the past year.
In the past year KIDS has reported a negative cash flow from operations.
KIDS had negative earnings in 4 of the past 5 years.
KIDS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of -4.78%, KIDS is doing good in the industry, outperforming 63.08% of the companies in the same industry.
KIDS's Return On Equity of -5.56% is fine compared to the rest of the industry. KIDS outperforms 65.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.78% | ||
| ROE | -5.56% | ||
| ROIC | N/A |
ROA(3y)-3.28%
ROA(5y)-5.52%
ROE(3y)-4.15%
ROE(5y)-7.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
KIDS has a better Gross Margin (74.80%) than 84.62% of its industry peers.
KIDS's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for KIDS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.8% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.11%
GM growth 5Y0.18%
2. Health
2.1 Basic Checks
KIDS does not have a ROIC to compare to the WACC, probably because it is not profitable.
KIDS has more shares outstanding than it did 1 year ago.
KIDS has more shares outstanding than it did 5 years ago.
KIDS has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 6.94 indicates that KIDS is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.94, KIDS belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
KIDS has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
KIDS's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. KIDS outperforms 63.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.94 |
ROIC/WACCN/A
WACC10.07%
2.3 Liquidity
A Current Ratio of 5.44 indicates that KIDS has no problem at all paying its short term obligations.
KIDS's Current ratio of 5.44 is fine compared to the rest of the industry. KIDS outperforms 72.31% of its industry peers.
KIDS has a Quick Ratio of 2.90. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
KIDS has a Quick ratio (2.90) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.44 | ||
| Quick Ratio | 2.9 |
3. Growth
3.1 Past
KIDS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.32%.
The Revenue has grown by 21.62% in the past year. This is a very strong growth!
KIDS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.89% yearly.
EPS 1Y (TTM)-1.32%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q17.14%
Revenue 1Y (TTM)21.62%
Revenue growth 3Y27.89%
Revenue growth 5Y20.89%
Revenue growth Q2Q21.37%
3.2 Future
KIDS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -9.80% yearly.
The Revenue is expected to grow by 22.56% on average over the next years. This is a very strong growth
EPS Next Y-25.2%
EPS Next 2Y-6.88%
EPS Next 3Y-9.8%
EPS Next 5YN/A
Revenue Next Year31.29%
Revenue Next 2Y25.36%
Revenue Next 3Y22.56%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for KIDS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KIDS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as KIDS's earnings are expected to decrease with -9.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.88%
EPS Next 3Y-9.8%
5. Dividend
5.1 Amount
KIDS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ORTHOPEDIATRICS CORP
NASDAQ:KIDS (4/26/2024, 3:30:02 PM)
After market: 30.26 0 (0%)30.26
+0.32 (+1.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap719.89M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.78% | ||
| ROE | -5.56% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.8% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.44 | ||
| Quick Ratio | 2.9 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1.32%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-25.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)21.62%
Revenue growth 3Y27.89%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y